The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium.
OBJECTIVE: In mice, haploinsufficiency of the IGF-1 receptor (IGF-1R(+/-)), at a whole-body level, increases resistance to inflammation and oxidative stress, but the underlying mechanisms are unclear. We hypothesized that by forming insulin-resistant heterodimers composed of one IGF-1Rαβ and one ins...
Príomhchruthaitheoirí: | Abbas, A, Imrie, H, Viswambharan, H, Sukumar, P, Rajwani, A, Cubbon, R, Gage, M, Smith, J, Galloway, S, Yuldeshava, N, Kahn, M, Xuan, S, Grant, P, Channon, K, Beech, D, Wheatcroft, S, Kearney, M |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2011
|
Míreanna comhchosúla
Míreanna comhchosúla
-
The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium
de réir: Abbas, A, et al.
Foilsithe / Cruthaithe: (2011) -
NOX2 NADPH-OXIDASE A NOVEL TARGET TO PREVENT INSULIN RESISTANCE RELATED ENDOTHELIAL CELL DYSFUNCTION
de réir: Sukumar, P, et al.
Foilsithe / Cruthaithe: (2012) -
TARGETING NOX2 NADPH OXIDASE IN INSULIN RESISTANCE RELATED ENDOTHELIAL DYSFUNCTION
de réir: Sukumar, P, et al.
Foilsithe / Cruthaithe: (2013) -
TARGETING NOX2 NADPH OXIDASE IN INSULIN RESISTANCE RELATED ENDOTHELIAL DYSFUNCTION
de réir: Sukumar, P, et al.
Foilsithe / Cruthaithe: (2013) -
Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction.
de réir: Sukumar, P, et al.
Foilsithe / Cruthaithe: (2013)